Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AlphaGeo provides an AI-powered geospatial platform that integrates climate risk, adaptation measures, and financial impact modeling to guide investment decisions. The company’s tools are used for risk assessment, due diligence, portfolio management, and site selection. Its proprietary indices and scenario modeling capabilities have been adopted by major institutional clients for real estate, infrastructure planning, and asset management. Notable results include enabling large homebuilders to identify resilient locations for development and supporting MARA in forecasting operational costs tied to climate risks.[1][3][4]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AlphaGeo.